Agilus Diagnostics IPO Date, Price, Lot Size & More: Check Details 

Click Here and Sign Up to Get Experts’ Verdicts on Agilus Diagnostics IPO

The IPO opening date for the Agilus Diagnostics IPO has not been announced yet, but the company has already filed its DRHP with SEBI/Exchange on 29th September 2023, and SEBI approval was received on 8th May 2025. It is a bookbuilding IPO of  ₹[.] crore shares. The issue will be listed on NSE and BSE, and the tentative date is yet to be announced.

Agilus Diagnostics IPO Details

The Agilus Diagnostics IPO date is not fixed yet. The face value of Agilus Diagnostics shares stands at ₹10 per share, and the IPO price band is fixed at [.] to [.] per share.

Kfin Technologies Limited is the registrar of the Agilus Diagnostics IPO and is responsible for managing the allotment process and initiating refunds. Check out the latest IPO details in the table below.

Agilus Diagnostics IPO Details 

Agilus Diagnostics IPO GMP 

Note: Agilus Diagnostics is yet to open. We will update the Agilus Diagnostics GMP data post an official announcement.

Agilus Diagnostics IPO DRHP Status

Agilus Diagnostics IPO Review

Check out the detailed Agilus Diagnostics IPO review for a thorough understanding of its potential to report listing gains. The Agilus Diagnostics IPO review will help you invest effectively to avoid significant losses. Explore more to make an informed Investment decision on this IPO.

Financial Health

Assess a company’s financial performance to know about its ability to sustain a competitive edge. Therefore, it is crucial to comprehend the business’s financial growth margins and declines before applying for the Agilus Diagnostics IPO.

Agilus Diagnostics Limited’s revenue decreased by 15.27% from ₹1,618.35 crores in March 2022 to ₹1,371.10 crores in March 2023. Moreover, the company’s PAT decreased by 78.97% from ₹554.71 crores to ₹116.64 crores. Investors can analyse other relevant factors and make a decision accordingly.

Agilus Diagnostics Limited’s IPO has shown consistent revenue growth, indicating that the company is financially stable. Moreover, brokers, investors, and RAs have a positive outlook for Milky Mist Dairy Foods’ IPO, particularly for its tentative listing day.

Technical Analysis

Some technical indicators are available to assess a company’s potential to deliver returns. Use the parameters mentioned below to analyse the technical aspects of the Agilus Diagnostics IPO

The PE ratio of Agilus Diagnostics Limited’s share is [.], and its Earnings Per Share (EPS) stands at [.]. Thus, the IPO of Agilus Diagnostics Limited can deliver gains on its tentative listing day.

Note: The data, as mentioned above, is taken from authentic sources and highlights pre-issue information. The PE ratio and EPS of Agilus Diagnostics Limited are subject to change after the IPO. Refer to the table below for post-issue updates on these two metrics. 

About the Agilus Diagnostics Limited Company Overview

Agilus Diagnostics Limited was established in 1995 and provides diagnostic testing services, including routine and specialised tests, wellness and preventive care packages, hospital laboratory management services, and clinical research trial testing services. As of March 31, 2023, the company operated a network of 413 laboratories, with 43 laboratories accredited by the National Accreditation Board for Testing and Calibration Laboratories (NABL). Agilus Diagnostics Limited maintains an international presence across regions, including the Middle East, Sub-Saharan Africa, the Commonwealth of Independent States, and the South Asian Association for Regional Cooperation (SAARC). During the fiscal year 2023, the company conducted 39.07 million tests and served 16.62 million patients in India and internationally.

Agilus Diagnostics Limited Financials

The company’s financial analysis is essential before applying for the IPO of Agilus Diagnostics Limited. Look at the table to learn about Agilus Diagnostics Limited’s financials. 

Explanation

Agilus Diagnostics Limited’s revenue decreased by 15.27% from ₹1,618.35 crores in March 2022 to ₹1,371.10 crores in March 2023. Moreover, the company’s PAT decreased by 78.97% from ₹554.71 crores to ₹116.64 crores. Investors can analyse other relevant factors and make a decision accordingly.

Agilus Diagnostics IPO Promoter Holdings

Have a look at the table below to check the holdings of Agilus Diagnostics Limited’s promoters: 

Note: The value will be calculated using Equity Dilution = Share Holding Pre-Issue –  Share Holding Post-Issue.

Agilus Diagnostics IPO Objectives

The primary aim of Agilus Diagnostics is to raise ₹ [.] crore. On the other hand, Agilus Diagnostics has decided to utilise these funds in different ways.

Should I Invest in Agilus Diagnostics IPO?

Explore the pros and cons of Agilus Diagnostics IPO to know whether you should apply or avoid the issue. These pros and cons may help you understand the IPO’s potential to deliver profits in the coming decades.

Pros of Agilus Diagnostics IPO

• Agilus Diagnostics has a well-balanced B2C and B2B revenue mix 
• The company offers a strong, comprehensive test suite, providing a single top solution for diagnostic needs. 
• The company has a strong parent and an experienced management team with significant industry experience.

Cons of Agilus Diagnostics IPO

• Agilus Diagnostics faces revenue declines and growth concerns
• The company has a dependence on the COVID-led and one-off revenue earlier
• The company has faced high valuation and return expectations  

How to Invest in the Agilus Diagnostics IPO?

Agilus Diagnostics has not opened yet. And most investors are still waiting for it. Here is how you will invest in Ayethe  Finance IPO after its opening. 

• Open a demat account or use your existing demat account to make a bid. 
• Navigate to the Agilus Diagnostics section to make an application.
• Select the number of lots you want to apply for and proceed with your application further. 
• Once you have applied for the Agilus Diagnostics  IPO, you will receive a mandate request on the selected mode of transaction.
• Approve the mandate request and get your application number instantly. 

How to Check Agilus Diagnostics IPO Allotment Status?

You can check for the Agilus Diagnostics IPO allotment in different ways. These include NSE and the registrar portal. Look at the steps mentioned below to check your allotment status online.

Check On NSE

• Visit the NSE Official Website.
• Navigate to the IPO Allotment Section. 
• Select Equity as the issue type. 
• Choose the Agilus Diagnostics IPO.  
• Choose whether to proceed with the PAN number or the application number.
• Submit your details to get the allotment status online. 

Check On the Registrar Portal

• Visit the registrar portal. 
• Click on the allotment option.
• Fill in the required details.
• Click on the submit button to know your Agilus Diagnostics allotment status.

Final Thoughts

Agilus Diagnostics is once again gathering investors’ attention with a positive announcement, set to be officially made on 8th May 2025. Kfin Technologies Limited has recently filed for Agilus Diagnostics worth ₹[.] crores with SEBI via a confidential route. The issue is subject to the approval of SEBI. Investors are cautious about Agilus Diagnostics’ IPO details, such as issue date, price band, lot size, subscription, and other key information.

Stay informed with Univest to get regular updates on the Agilus Diagnostics  IPO, GMP, subscription, and more!

FAQs on Agilus Diagnostics IPO

When did Agilus Diagnostics file IPO draft papers?

Ans. Agilus Diagnostics filed its updated draft papers with SEBI for an IPO of up to ₹[.] crore shares on 29th September 2023.

What are the uses of IPO proceeds?

Ans. Agilus Diagnostics has raised funds through its IPO to expand its business operations. 

Is Agilus Diagnostics a publicly listed company?

Ans. Agilus Diagnostics is listed on stock exchanges, so it is a publicly listed company. Agilus Diagnostics had gone public through an IPO filing of ₹[.] crore shares.

What is the issue size for Mist Dairy Foods?

Ans. It is a bookbuilding IPO comprising a fresh issue and offer for sale to raise approximately ₹[.] crore shares. 

Is Agilus Diagnostics good?

Ans:  Agilus Diagnostics Limited’s revenue decreased by 15.27% from ₹1,618.35 crores in March 2022 to ₹1,371.10 crores in March 2023. Moreover, the company’s PAT decreased by 78.97% from ₹554.71 crores to ₹116.64 crores. Investors can analyse other relevant factors and make a decision accordingly.

Who will be the registrar of the Agilus Diagnostics IPO?

Ans. As per the recent updates, Kfin Technologies Limited will be the registrar responsible for managing allotment and refund procedures. For any queries regarding Agilus Diagnostics GMP, allotment, and refund, you can contact Kfin Technologies Limited at adl.ipo@kfintech.com  or 04067162222, 04079611000. 

Disclaimer: The above information is compiled from authentic sources and is just for informational purposes. To obtain detailed information about the Agilus Diagnostics IPO, please wait for the RHP and DRHP to be released by Milky Mist Dairy Foods. Conduct thorough research before investing in IPOs to minimise the risk of significant losses. You can also consult your financial advisor.

Upcoming IPOs

Current & Previous IPOs

Read Our Articles on the Best Stocks

Tech Stocks in India to Invest in 2025 | Tech Sector Stocks 

Best Battery Stocks in India to Invest in 2025 | Battery Sector Stocks 

Best Shipping Stocks in India to Invest in 2025 | Shipping Sector Stocks 

Paint Stocks in India to Invest in 2025 | Paint Sector Stocks 

Paper Stocks in India to Invest in 2025 | Paper Sector Stocks 

Best Semiconductor Stocks in India 2025 

Best Large Cap Stocks in India 2025 

Green Energy Penny Stocks

Best Cement Stocks To Invest in India

Also Explore

Univest Screeners